To investigate the involvement of activated B cells in the pathogenesis of IPAH, we studied an autoimmune-prone mouse model with enhanced BCR signalling, as well as circulating B cells and T cells in three groups of patients with PAH. This evidence concerns the gene BCR and idiopathic pulmonary arterial hypertension.